Sort
172,184 grants matching “inflammation”
Longitudinal imaging of microglial activation in different clinical variants of Alzheimer's disease
$972,355William Charles Kreisl · Columbia University Health Sciences · R01 · FY2020 · AG
ADalimumab Vs. conventional ImmunoSupprEssion for uveitis(ADVISE) Trial
$972,337Janet T. Holbrook · Johns Hopkins University · UG1 · FY2022 · EY
GWAS of Hormone Treatment and CVD and Metabolic Outcomes in the WHI
$972,278Alexander P Reiner · Fred Hutchinson Cancer Research Center · U01 · FY2011 · HG
Breast White Adipose Tissue Inflammation and Breast Cancer Outcomes
$972,130Lawrence H Kushi · Kaiser Foundation Research Institute · R01 · FY2021 · CA
Anti-carcinogenic Activity Of Cox inhibitors and NAG-1
$972,039Thomas Eling · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
Gastroesophageal junction stem cells as the origin of Barretts esophagus and cancer
$972,000Timothy Cragin Wang · Columbia University Health Sciences · R01 · FY2022 · CA
Mechanisms addressing the causal relationships of sleep, circadian rhythms, and cardiometabolic health
$972,000Marie-Pierre St-Onge · Columbia University Health Sciences · R35 · FY2025 · HL
Glycans in Blood Homeostasis and Disease
$972,000Karin Maria Hoffmeister · Versiti Wisconsin, Inc. · K12 · FY2019 · HL
Glycans in Blood Homeostasis and Disease
$972,000Karin Maria Hoffmeister · Versiti Wisconsin, Inc. · K12 · FY2021 · HL
Glycans in Blood Homeostasis and Disease
$972,000Karin Maria Hoffmeister · Versiti Wisconsin, Inc. · K12 · FY2022 · HL
Glycans in Blood Homeostasis and Disease
$972,000Karin Maria Hoffmeister · Versiti Wisconsin, Inc. · K12 · FY2020 · HL
Asthma and Allergic Disease Center
$971,931Thomas A. Platts-Mills · University Of Virginia · U19 · FY2008 · AI
A Systems-level Approach to Studying HIV/AIDS Susceptibility and Substance Abuse
$971,870Steven M Wolinsky · Northwestern University At Chicago · R01 · FY2012 · DA
Neuroprotective role of GLP-1 receptor agonists
$971,839Nigel H. Greig · National Institute On Aging · ZIA · FY2021 · AG
Candidate selection of a LPAR1 antagonist for therapeutic application in NASH
$971,732Fabio Cohen Tucci · Epigen Biosciences, Inc. · R44 · FY2023 · DK
Studies of neurocysticercosis and animal cestode infections
$971,721Theodore Nash · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Immune checkpoint inhibitors and accelerated coronary atherosclerosis
$971,495Tomas G Neilan · Massachusetts General Hospital · R01 · FY2024 · HL
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
$971,355Ira A Tabas · Columbia University Health Sciences · R35 · FY2021 · HL
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
$971,347Ira A Tabas · Columbia University Health Sciences · R35 · FY2022 · HL
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
$971,337Ira A Tabas · Columbia University Health Sciences · R35 · FY2023 · HL
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
$971,319Ira A Tabas · Columbia University Health Sciences · R35 · FY2025 · HL
Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis
$971,267Yow-Pin Lim · Prothera Biologics, Llc · R44 · FY2025 · AI
Antimicrobial and Regenerative Treatment for Oral Mucositis
$970,980Shenda Baker · Synedgen, Inc. · R44 · FY2012 · DE
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)
$970,881Andrew Redd · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Plasma Gelsolin as Immunotherapeutic for Antibiotic-Resistant Pneumonia
$970,844Lester Kobzik · Harvard School Of Public Health · R01 · FY2017 · AI